Dorzolamide Hydrochloride Solution/ Drops
Product Images NDC 25021-006

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride (NDC 25021-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dor03 0000 01)

Structural Formula (Dor03 0000 01)
Chemical structure of Dorzolamide Hydrochloride, illustrating its molecular framework including sulfonamide and thiophene groups with hydrochloride.*
FDA Label Image

Figure A (Dor03 0000 02)

Figure A (Dor03 0000 02)
An illustration showing parts of an ophthalmic solution bottle labeled as 'Cap,' 'Tamper evident ring,' and 'Bottle.' The diagram highlights the components of the bottle used for dispensing eye drops.*
FDA Label Image

Figure B (Dor03 0000 03)

Figure B (Dor03 0000 03)
Illustration showing a hand holding an ophthalmic solution bottle while the other hand twists the cap to open it, depicting how to open a dropper bottle for eye drops.*
FDA Label Image

Figure C (Dor03 0000 04)

Figure C (Dor03 0000 04)
An instructional black and white line drawing showing the top portion of an ophthalmic solution bottle with a child-resistant cap. The cap features twisting arrows indicating the direction to turn for removal or securing, demonstrating how to open or close the bottle.*
FDA Label Image

Figure D (Dor03 0000 05)

Figure D (Dor03 0000 05)
An instructional line drawing depicting a hand administering an ophthalmic drop into an eye. The illustration shows a side profile of a face with one eye open and a finger positioned near the lower eyelid, suggesting the application of eye drops.*
FDA Label Image

Figure E (Dor03 0000 06)

Figure E (Dor03 0000 06)
An instructional diagram showing how to administer ophthalmic solution eye drops. One image shows a hand holding a bottle above an open eye, and the other is a close-up of a dropper releasing a drop into the eye. The illustration demonstrates proper eye drop instillation technique.*
FDA Label Image

Figure F (Dor03 0000 07)

Figure F (Dor03 0000 07)
An instructional illustration showing a person holding an ophthalmic solution bottle and twisting the cap to open it, demonstrating how to prepare the dropper for use.*
FDA Label Image

Package Label – Principal Display Panel – Bottle Label (Dor03 0000 08)

Package Label – Principal Display Panel – Bottle Label (Dor03 0000 08)
Label for Dorzolamide Hydrochloride 2% ophthalmic solution, 10 mL, sterile drops for topical application in the eye. Manufactured by Sagent Pharmaceuticals. Includes NDC 25021-006-10, barcode, and storage instructions, with branding on a blue and orange background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.